Recombinant Human Galectin-9 is produced by our expression system and the target gene encoding Met1-Thr322 is expressed
Recombinant Human Galectin-9/LGALS9 (N-GST)
SKU: CR37-10ug
$76.00Price
top of page
[{"key":"CR37-50ug","value":"Backorder"},{"key":"CR37-1mg","value":"Backorder"},{"key":"CR37-10ug","value":"Backorder"},{"key":"CR37-500ug","value":"Backorder"}]
Contact Us
Shipping Information
$48 Standard Overnight flat rate for products shipped in room temperature within the United States.
Additional $27 Ice Packs shipment fee is required for liquid proteins.
Please contact us to order for international shipments.
Endotoxin
Less than 0.1 ng/ug (1 EU/ug) as determined by LAL test.
Accession Number
O00182-2
Species
Human
Expression System
E.coli
Target Sequence
Met1-Thr322
Tag
N-GST
Formulation
Supplied as a 0.2 um filtered solution of 1M PBS, 100 mM GSH, 1% Tritonx-100, 15% Glycerol, pH 8.0.
Packaging
Dry Ice/ice packs
Background
Galectin-9 is a cytoplasmic protein that contains two galectin domains. Galectin-9 is an S-type lectin that is over-expressed in Hodgkin's disease tissue. Galectin-9 binds galactosides and has high affinity for the Forssman pentasaccharide. Galectin-9 plays a role in thymocyte-epithelial interactions relevant to the biology of the thymus and Inhibits cell proliferation. Galectin-9 is a ligand for HAVCR2/TIM3 and induces T-helper type 1 lymphocyte (Th1) death. In addition, Galectin-9 suppresses tumor cell metastasis by interfering with the associations CD44, VCAM-1, Integrin α4β1
Purity
Greater than 90% as determined by reducing SDS-PAGE.
Galectin-9; Gal-9; Ecalectin; Tumor antigen HOM-HD-21; LGALS9; Gal-9delta5
Alternative Names
Be the first to submit a citation to get publication rewards
Citation
NA
Activity
bottom of page